Evaluation of the Association between FGFR2 Gene Polymorphisms and Breast Cancer Risk in the Bangladeshi Population
Authors:
- Nusrat JahanNJNusrat Jahan
- Mobashera BegumMBMobashera Begum
- Abdul BarekABAbdul Barek
- Abdul AzizAAAbdul Aziz
- Shafiul HossenSHShafiul Hossen
- Khokon Kanti BhowmikKBKhokon Kanti Bhowmik
- Tahmina AkterTATahmina Akter
- Rabiul IslamRIRabiul Islam
- Hadi Sajid AbdulabbasHAHadi Sajid Abdulabbas
- Mohammad Safiqul IslamMIMohammad Safiqul Islam
Open Access
Abstract
Breast cancer is considered the most frequent cause of mortality from malignancy among females. Fibroblast growth factor receptor 2 (FGFR2) gene polymorphisms are highly related to the risk of breast cancer. However, no investigation has been carried out to determine the association of FGFR2 gene polymorphisms in the Bangladeshi population. Based on polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP), this study was performed to evaluate the association of FGFR2 (rs1219648, rs2420946, and rs2981582) variants in 446 Bangladeshi women (226 cases and 220 controls). A significant association of the FGFR2 rs1219648 variant with breast malignancy was reported in additive model 1 (aOR = 2.87, p < 0.0001), additive model 2 (aOR = 5.62, p < 0.0001), the dominant model (aOR = 2.87, p < 0.0001), the recessive model (aOR = 4.04, p < 0.0001), and the allelic model (OR = 2.16, p < 0.0001). This investigation also explored the significant association of the rs2981582 variant with the risk of breast cancer in additive model 2 (aOR = 2. 60, p = 0.010), the recessive model (aOR = 2.47, p = 0.006), and the allelic model (OR = 1.39, p = 0.016). However, the FGFR2 rs2420946 polymorphism showed no association with breast cancer except in the overdominant model (aOR = 0.62, p = 0.048). Furthermore, GTT (p < 0.0001) haplotypes showed a correlation with breast cancer risk, and all variants showed strong linkage disequilibrium. Moreover, in silico gene expression analysis showed that the FGFR2 level was upregulated in BC tissues compared to healthy tissues. This study confirms the association of FGFR2 polymorphisms with breast cancer risk.Keywords
Funding Information
- Noakhall Science and Technology University and National Science and Technology University (NSTU/RC/19/C-84)
- National Science and Technology (NST) (NSTU/RC/19/C-84)
This publication has 37 references indexed in Scilit:
- Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American populationBreast Cancer Research and Treatment, 2012
- Fibroblast growth factors and their receptors in cancerBiochemical Journal, 2011
- GP369, an FGFR2-IIIb–Specific Antibody, Exhibits Potent Antitumor Activity against Human Cancers Driven by Activated FGFR2 SignalingCancer Research, 2010
- Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West SiberiaEuropean Journal of Human Genetics, 2009
- The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defectsHuman Molecular Genetics, 2009
- Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast CancerPLOS Biology, 2008
- FGFR2 Is a Breast Cancer Susceptibility Gene in Jewish and Arab Israeli PopulationsCancer Epidemiology, Biomarkers & Prevention, 2008
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerNature Genetics, 2007
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006